Page 162 - Let them speak Towards a patient reported outcome measure set for

Chapter 6
Prinsen, C. A. C., L. B. Mokkink, L. M. Bouter, et al. 2018. COSMIN guideline for systematic reviews
of patient-reported outcome measures. Qual Life Res, 27, 1147–1157.
Rare Disease Patient Compendium. 2022. Guide To Patient Involvement In Rare Disease Therapy
Development. https://everylifefoundation.org/wp-content/uploads/2022/01/Guide-to-
Patient-Involvement-FINAL-COMPLETE-GUIDE-Rev.pdf.
RD-COAC. 2023. Rare Disease COA Resource [Online]. Available: https://rdcoas.c-path.org/
[Accessed].
Rivera, S. C., D. G. Kyte, O. L. Aiyegbusi, A. L. Slade, C. Mcmullan, andM. J. Calvert. 2019. The impact
of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical
analysis. Health and Quality of Life Outcomes, 17, 1–19.
Robertson, J., S. Baines, E. Emerson, and C. Hatton. 2018. Prevalence of constipation in people with
intellectual disability: a systematic review. Journal of Intellectual & Developmental Disability,
43, 392–406.
Robertson, J., C. Hatton, E. Emerson, and S. Baines. 2015. Prevalence of epilepsy among people
with intellectual disabilities: a systematic review. Seizure, 29, 46–62.
Schjoedt, I., I. Sommer, and M. B. Bjerrum. 2016. Experiences and management of fatigue in
everyday life among adult patients living with heart failure: a systematic review of qualitative
evidence. JBI Evidence Synthesis, 14, 68–115.
Schützwohl, M., A. Koch, N. Koslowski, et al. 2016. Mental illness, problem behaviour, needs and
service use in adults with intellectual disability. Social Psychiatry and Psychiatric Epidemiology,
51, 767–776.
Swain, M. G. 2000. Fatigue in chronic disease. Clinical Science, 99, 1–8.
Teela, L., M. M. van Muilekom, L. H. Kooij, et al. 2021. Clinicians’ perspective on the implemented
KLIK PROM portal in clinical practice. Quality of Life Research, 30, 3267–3277.
Ustun, T. B., S. Chatterji, J. Bickenbach, N. Kostanjsek, and M.Schneider. 2003. The international
classification of functioning, disability and health: A new tool for understanding disability and
health. Disability and Rehabilitation, 25.
Valderas, J. M., and J. Alonso. 2008. Patient reported outcome measures: a model-based
classification system for research and clinical practice. Qual.Life Res., 17, 1125–1135.
van Eeghen, A. M., H. Bruining, N. I. Wolf, et al. 2022. Personalized medicine for rare neurogenetic
disorders: can we make it happen? Molecular Case Studies, 8, a006200.
van Muilekom, M. M., L. Teela, H. A. van Oers, J. B. van Goudoever, M. A. Grootenhuis, and L.
Haverman. 2022. Patients’ and parents’ perspective on the implementation of Patient
Reported Outcome Measures in pediatric clinical practice using the KLIK PROM portal. Quality
of Life Research, 31, 241–254.
van Silfhout, N. Y., M. M. van Muilekom, C. D. van Karnebeek, J. G. Daams, L. Haverman, and A. M.
van Eeghen. 2025. Patient reported outcomes used in clinical trials and core outcome sets for
individuals with genetic intellectual disability: a scoping review. Journal of Neurodevelopmental
Disorders, 17, 43.
van Silfhout, N. Y., M. M. van Muilekom, C. D. van Karnebeek, L. Haverman, and A. M. van Eeghen.
2024. PROs for RARE: protocol for development of a core patient reported outcome set for
individuals with genetic intellectual disability. Orphanet Journal of Rare Diseases, 19, 1–9.
van Silfhout, N. Y., M. M. van Muilekom, C. D. van Karnebeek, L.Haverman, and A. M. van Eeghen.
2025. Patient reported outcomes that matter to individuals with (genetic) intellectual
disabilities: a qualitative study. Journal of Neurodevelopmental Disorders, 17, 57.
Williamson, P. R., D. G. Altman, H. Bagley, et al. 2017. The COMET handbook: version 1.0. Trials, 18,
1–50.
Williamson, P. R., D. G. Altman, J. M. Blazeby, et al. 2012. Developing core outcome sets for clinical
trials: issues to consider. Trials, 13, 1–8.
Wilson, I. B., and P. D. Cleary. 1995. Linking clinical variables with health-related quality of life. A
conceptual model of patient outcomes. JAMA, 273.
160